ModuLight.bio

Pioneering a new era of medicine for people living with neurological disorders using light-based therapies.

Health Tech & Life Sciences
Active
Seed Ramat Gan, Israel Founded 2022
Last updated 2026-08-23
Total raised
—
Last: Undisclosed Round 2025-07
Stage
Seed
Founded
2022
Headcount
23
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

Modulight Biotherapeutics is developing a novel optogenetics-based platform, eOPN3, to treat severe neurological disorders. This innovative approach uses gene therapy to introduce light-sensitive proteins into targeted neurons, allowing for precise control of brain activity using light. The platform aims to provide lasting relief for conditions such as trigeminal neuropathic pain, drug-resistant epilepsy, and movement disorders by silencing pathological neural communication. The company emphasizes its strong team of scientists and clinicians dedicated to transforming the future of neurology.

Headcount over time

23 employees (2026-09) · 1 point
23 23 2026-09

Offices

Ramat Gan, Israel · HQ / main office

Q&A

What is ModuLight.bio's primary focus?
ModuLight.bio is developing an optogenetics-based platform for treating neuronal overactivation disorders.
When was ModuLight.bio founded?
ModuLight.bio was founded in April 2022.
How many employees does ModuLight.bio have?
ModuLight.bio has 11-50 employees.
What is ModuLight.bio's current funding stage?
ModuLight.bio is currently in the Seed funding stage.
Which investors participated in ModuLight.bio's $6.7 million funding round?
Jibe Ventures and Secret Chord Ventures participated in ModuLight.bio's $6.7 million funding round.
Which investors participated in ModuLight.bio's July 2025 funding round?
Nexus NeuroTech Ventures and Philippe Suchet participated in ModuLight.bio's funding round in July 2025.
What is the total amount ModuLight.bio has raised to date?
ModuLight.bio has raised a total of $6.7 million USD.
In which sector does ModuLight.bio primarily operate?
ModuLight.bio operates primarily in the Health Tech & Life Sciences sector.

Team · 25

Ofir Levi
Founder · Co-Founder and Chairman of the Board
Yotam Eldar
Founder · Co-Founder and Chief Executive Officer
Ofer Yizhar
Founder · Scientific co-founder and Chief Scientist
Yoav Kfir
VP of Research and Development
Genine Winslow
Head of Gene Therapy
Tamar Shai Granot
Director of Product
Sasha Devore
Director of Scientific Communications and Engagement
Evyatar Swissa
Director of In-vivo Research
Dahlia Kushinsky
Scientific Director of Collaborative Research
Noam Shuv
Chief of Staff
Ziv Spada
Director of Operations
Shelly Burda
System Engineer
Gal Toren
R&D Analyst
Shoshan Sharon
Clinical Analyst
Danny Hadar
Board of Directors
Julia Hawkins
Board of Directors
Jacob Orry Fierer
Board of Directors
Maria Kousi
Director of Life Science Investments, CNS at a private family office based in Silicon Valley
Karl Deisseroth
Scientific Advisory Board
Hagai Bergman
Scientific Advisory Board
Andreas Horn
Scientific Advisory Board
Iris Grossman
Scientific Advisory Board
Lief Fenno
Scientific Advisory Board
Alex Rotenberg
Scientific Advisory Board
Steven Goetz
Scientific Advisory Board

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B

Highlights

1 PatentsVerified

Tags

neuro-stimulationpharmaceuticalsneurology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemodulight.bio/

Identifiers & details

Founded2022-4
Employees (exact)23

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainmodulight.bio

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516599768
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-04-14
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events1 — other (1)
Registered addressהיצירה 24 רמת גן

Recent registry events

DateEvent
2026-07-24עדכון כתובת ו/או מען דיגיטלי